Nerve-blocking agents could be used together with radiation and other currently available treatment regimens, the researchers said.
Representative image. (Wikimedia Commons)
Nerve-blocking agents could be used together with radiation and other currently available treatment regimens to stop or slow certain head and neck cancers from growing, new research has found. By performing RNA sequencing on human tumour tissue, the researchers found sensory nerves released a protein called calcitonin, a gene-related peptide that directly inhibited the immune cells in the tumour environment.